LEAH HUNTER: Open Payments
NPI 1619515632 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 43 payments from 8 companies in 2025. Trend: 2023 $910 · 2024 $485 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 10 | $270 |
| Teva Pharmaceuticals USA, Inc. | 13 | $257 |
| E.R. Squibb & Sons, L.L.C. | 9 | $187 |
| Janssen Pharmaceuticals, Inc | 4 | $95 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| Alkermes, Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $15 |
Products named: INGREZZA, UZEDY, COBENFY, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across SC — which companies pay providers there.
